Anlon Healthcare IPO GMP & Review: Apply or Avoid?

Anlon Healthcare IPO is open for bidding from August 26, 2025, to August 29, 2025. It is a bookbuilding IPO of  ₹121.03 crore, comprising a fresh issue of 1.33 crore shares. The problem will be listed on BSE and SME on its tentative listing date, 3rd September 2025. 

Anlon Healthcare IPO Details 

The Anlon Healthcare IPO date is fixed between 26th August 2025 and 29th August 2025. The face value of Anlon Healthcare IPO shares stands at ₹10 per share, and the IPO price is set at ₹86.00 to 91.00 per share.

Maashitla Securities Private Limited is the registrar of the Anlon Healthcare IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Anlon Healthcare IPO Share Reservation

Anlon Healthcare IPO is a bookbuilding IPO of ₹121.03 crores, comprising a fresh issue of 1.33 crore shares of Anlon Healthcare, which will be listed on the BSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Anlon Healthcare IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Anlon Healthcare IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 22nd August 2025, Anlon Healthcare IPO GMP stands at ₹0 per share, which means the share will likely show a listing at ₹91 on its tentative listing date, 2nd September 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Anlon Healthcare GMP. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Anlon Healthcare IPO GMP Review

Check out the detailed Anlon Healthcare GMP IPO review for a thorough understanding of its potential to report listing gains on 3rd September 2025. The Anlon Healthcare IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business’s financials before applying for the Anlon Healthcare IPO.

Anlon Healthcare Limited’s revenue increased by 81% from ₹69.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores.

Anlon Healthcare Limited’s IPO has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the Anlon Healthcare IPO for its tentative listing day, 3rd September 2025.  

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Anlon Healthcare IPO.

The P/E ratio of Anlon Healthcare Limited’s share is 17.67, and its Earnings Per Share (EPS) stands at 5.15. Thus, the Anlon Healthcare Limited IPO can potentially deliver gains on its tentative listing date, 3rd September 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Anlon Healthcare Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Anlon Healthcare Limited IPO Peer Comparison

Anlon Healthcare IPO Subscription Status

The Anlon Healthcare IPO is to be opened for bidding on 26th August 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Anlon Healthcare IPO subscription status. 

About Anlon Healthcare Limited

Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of high-purity advanced pharmaceutical intermediates, which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients. The company also undertakes API development, preparation, and filing of Drug Master File (DMF) in the Indian and global markets as per the pharmacopoeia requirements of customers and regulatory agencies. In addition to the manufacturing of Pharma Intermediates and APIs in accordance with various domestic and international standards, we have recently started undertaking custom manufacturing services for complex or novel chemical compounds, tailoring the manufacturing process to meet specific customer requirements, including producing chemicals with purity levels that exceed industry standards. 

Anlon Healthcare Limited Financials

The company’s financial analysis is essential before applying for the Anlon Healthcare  IPO. Look at the table to learn about Anlon Healthcare Limited’s financials. 

Explanation

Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores.

Anlon Healthcare IPO Bidding Requirements

Investors can bid for a minimum of 164 shares and in multiples of 164 shares thereof. The following table represents the minimum and maximum investments by individual investors (retail) and HNI in terms of shares and amount.

Anlon Healthcare IPO has reserved lot sizes for different investor categories. Look at the table below to see the requirements for applying for this IPO.

Use the lot size calculator to find how many shares you should apply for!

Anlon Healthcare IPO Promoter Holding

Have a look at the table below to check the holdings of Anlon Healthcare Limited’s promoters: Mr. Debajit Choudhury, Ms. Rina Choudhury, Ms. Susmita Mukherjee, Ms. Debahuti Chatterjee, and Ms. Nita Dey.

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue –  Share Holding Post-Issue.

Aim of the Anlon Healthcare IPO

The primary aim of the Anlon Healthcare IPO is to raise ₹121.03 crores. On the other hand, Anlon Healthcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Anlon Healthcare IPO.

• To meet the general corporate purpose.
• To fund the working capital of the company.

Should I Invest in the Anlon Healthcare IPO?

Explore the pros and cons of Anlon Healthcare to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO’s efficiency in delivering profits in the coming decades. 

    Pros of Anlon Healthcare IPO

• Anlon Healthcare has strong revenue and profit growth, and has earned revenue nearly doubled from FY24 to FY25, showing positive business momentum.
• The company claims to be the first one to manufacture Loxoprofen and related products.
•  The company has good domestic market sales in India and has expanded its operations globally with customers in over 15 countries.
• Funds will drive capacity expansion, debt repayment, and working capital support, aligning well with the growth strategy.

Cons of Anlon Healthcare IPO

• The company is subject to strict technical specifications, quality requirements, regular inspections, and audits by its customers or other representatives.
• Its revenue from operations is dependent upon a limited number of customers, and the loss of any of these customers will lead to a loss of revenue.
• The company derives a significant portion of its revenue from its operations in India. The reduction in demand for its product in the domestic market could adversely affect its revenue.
• The company operates only a single manufacturing facility, located in Rajkot, Gujarat,, which exposes them to potential geographical risks.

How to Apply for the Anlon Healthcare IPO?

Check the steps mentioned below to apply for Anlon Healthcare Limited.

• Step 1: Conduct thorough research on the Anlon Healthcare IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for two lots of 164 shares worth ₹14,924.
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Anlon Healthcare IPO from more than one demat account to increase your chances of allotment. 

How to Check Anlon Healthcare IPO Allotment Status?

You can check whether the Anlon Healthcare IPO allotment has been completed in different ways. These include BSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On BSE

• Visit the BSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Anlon Healthcare IPO.  
• Choose whether to proceed with the PAN number or the application number. 
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Anlon Healthcare IPO allotment status.

Let’s Wrap

Anlon Healthcare IPO is a bookbuilding issue of shares worth ₹121.03 crores. The shares of Anlon Healthcare Limited will be listed on BSE and SME on its tentative listing date of 3rd September 2025. Researching the Anlon Healthcare IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

Also Read : ARC Insulation & Insulators IPO GMP & Review: Apply or Avoid?

FAQs on Anlon Healthcare IPO

How is the Anlon Healthcare IPO?

Ans. Currently, on 23rd August 2025, the Anlon Healthcare IPO GMP (Grey Market Premium) stands at ₹18. It indicates that the estimated listing price could be ₹91 per share. It is a bookbuilding IPO of ₹121.03 crores, comprising a fresh issue of 1.33 crore shares. The face value of each share of Anlon Healthcare Limited is ₹10 per share.

What is the Anlon Healthcare IPO price?

Ans. The Anlon Healthcare IPO price is set at ₹86.00 to 91.00 per share.  Retail investors can apply for a minimum of 1 lots consisting of 148 shares worth ₹14,356. Moreover, HNIs are required to bid for a minimum of 14 lots (2,296 shares) worth ₹2,08,936.

Is the Anlon Healthcare IPO good?

Ans. Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores.

Who is the registrar of the Anlon Healthcare IPO?

Ans. Maashitla Securities Private Limited is the registrar of the Anlon Healthcare IPO, responsible for managing the IPO allotment procedure and refund initiation. For any queries regarding the Anlon Healthcare allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com,+91-11-45121795-96. 

What is the issue size of the Anlon Healthcare IPO?  

Ans. Anlon Healthcare IPO is a bookbuilding IPO for 1.33 crore shares worth ₹121.03 crores. Moreover, the IPO is set to open on 26th August 2025 and will be closed on 29th August 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Anlon Healthcare IPO, download the Anlon Healthcare IPO RHP and Anlon Healthcare IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks